Pharmaceutical Cybersecurity
Built for Every Connected Environment
Protect your drug research and manufacturing networks without agents or scanning. Pharmaceutical networks run devices that traditional security tools cannot reach. ORDR discovers and protects every connected asset across your environment, from lab instruments to production OT, without disrupting a single process.
How ORDR Secures Pharmaceutical Environments
ORDR uses passive network traffic analysis to discover and profile every connected device. No agents. No active scanning. No interaction with validated systems.
Initial discovery is completed within 48-72 hours. ORDR then generates segmentation policies from actual device behavior. Every policy runs against live traffic before enforcement, so no change disrupts manufacturing or research.
| Environment | Security Challenge | How ORDR Responds |
|---|---|---|
| Research Labs | Lab analyzers and instruments without agent support | Passive discovery profiles every device; behavioral AI detects anomalies |
| Drug Manufacturing | PLCs, HMIs, and SCADA systems on flat networks prone to lateral movement | Protocol-aware classification with validated microsegmentation enforces isolation |
| Quality Control | QC instruments connected to enterprise IT without device-level controls | Device-level segmentation enforces least-privilege access |
| Third-Party Access | Vendor connections introduce unmanaged devices and unknown risk | Real-time visibility flags unrecognized devices the moment they connect |
Why Pharmaceutical Organizations Choose ORDR
No-Agent Discovery
ORDR identifies every device through passive traffic analysis. No scanning, no credentials, no risk to GxP or clean-room environments.
AI Trained on 100M+ Real-World Devices
Accurate profiling covers lab analyzers, bioreactors, and proprietary manufacturing protocols, including equipment from thousands of manufacturers.
Segmentation in Weeks, Not Months
Pharma organizations deploy validated segmentation policies in days or weeks, replacing projects that previously took 12-24 months.
Works With Existing Security Infrastructure
ORDR integrates with the firewalls and NAC platforms you already operate. No rip-and-replace required.
Trusted by 500+ Enterprises
SOC 2 Type II Certified.
Pharma Is the Top Target and the Hardest Environment to Secure
Deloitte research identifies pharma as the top global target for IP theft. The connected devices that carry that IP cannot run traditional security agents. Most tools leave them completely unprotected.
The challenge is not identifying risk. Your team can see it. The challenge is acting on it safely, across every device type, without disrupting regulated operations.
What Attackers Target
- Drug formulas and active research data
- Clinical trial results and regulatory filings
- Manufacturing control systems and production networks
- Patient records tied to active clinical programs
| Threat Indicator | Metric | Source |
|---|---|---|
| Average pharmaceutical data breach cost | $4.61 million | IBM Cost of a Data Breach Report, 2025 |
| Ransomware attacks on OT systems | Up 46% in Q1 2025 | Honeywell Cyber Threat Report, 2025 |
| Pharma companies affected by third-party breaches | 87% | BlueVoyant, 2024 |
Regulatory Alignment for Pharmaceutical Environments
The FDA published OT Cybersecurity Guidance for pharmaceutical manufacturing in June 2025. It requires complete asset inventory, zone-and-conduit architecture, and continuous monitoring. ORDR delivers all three through your existing network infrastructure.
| Regulation / Framework | Core Requirement | How ORDR Delivers |
|---|---|---|
| FDA OT Cybersecurity Guidance (June 2025) | Asset visibility, zone segmentation, IEC 62443 alignment | Passive OT discovery; automated zone-based policy generation |
| 21 CFR Part 11 / GxP | Data integrity and audit trail for electronic records systems | Continuous device activity logging; audit-ready compliance reports |
| HIPAA | Access controls and transmission security for patient data | Least-privilege enforcement; detection of unencrypted transmissions |
| IEC 62443 | Zone and conduit architecture for industrial control systems | Behavior-based policies aligned with industrial zone requirements |
Common Questions from Pharmaceutical Security Leaders
See how ORDR protects every
connected device
In your pharmaceutical environment, from research to production.
SOC 2 Type II Certified · HIPAA Compliant · Trusted by 500+ Enterprises